Attached files

file filename
8-K - FORM 8-K - Lifeloc Technologies, Inclifeloc_8k.htm


Exhibit 99.1
 
Lifeloc Reports Third Quarter 2018 Results

WHEAT RIDGE, Colo., November 13, 2018 -- Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol testing devices, has announced financial results for the third quarter ended September 30, 2018.
Third Quarter Financial Highlights
We posted quarterly net revenue of $2.06 million resulting in quarterly net income after taxes of $58 thousand, or $0.02 per diluted share.  These results compare to net revenue of $2.00 million for quarterly net income of $190, or $0.00 per diluted share, in the second quarter of 2017.  Revenue for the quarter grew 3% versus the third quarter last year and year to date revenue grew for the first nine months of 2018 6% versus the first nine months last year.
This quarter was the fourth consecutive quarter with year over year growth as our distribution channels improve.  Gross margin on net revenue improved in the current quarter to 46% versus 44% in the same quarter last year primarily due modestly better volume and a better product mix.
Strategic Highlights
Our vision is that Lifeloc becomes the world’s leading company in real-time alcohol and drug abuse detection and monitoring.  To that effect, we continue to invest aggressively in research and development.  This investment amounted to 13% of revenue for the first 9 months of the year.  Lifeloc has focused product development on three specific fronts.
·
We will continue to push the bounds on our core portable breathalyzer business as we build a completely new breathalyzer platform with features that customers have demanded.  Keeping our core business at the leading technical edge is critical as the core business allows us to fund our growth opportunities.   This new breathalyzer platform is expected to begin limited production before the end of this year, with full scale production in the first quarter 2019.

·
We will build our alcohol monitoring business utilizing the Real-time Alcohol Detection and Recognition or R.A.D.A.R.® device product line acquired last year.  R.A.D.A.R. devices are alcohol monitoring units with biometrics which can be used as a tool to supervise offenders as an alternative to incarceration.  The upgraded R.A.D.A.R. device – with a more robust design and better communications – is expected to relaunch in the first quarter of 2019.

·
The marijuana breathalyzer took a step closer to realization with the detection of delta-9-THC (the psychoactive agent) captured from a vapor sample.  The ability of our technology to detect delta-9-THC down to a concentration of 5 nanograms per milliliter has been demonstrated in our laboratories.  Detection is accomplished through the SpinDx technology, licensed exclusively by Lifeloc Technologies for drugs of abuse from Sandia National Laboratory.  More work is needed to convert this technology into a simple-to-operate device suitable for roadside testing.  The next step is human testing of the collection and detection mechanism.

“We are working hard to improve the business through investment both in infrastructure and new product development,” commented Dr. Wayne Willkomm, President and CEO.  “We are nearing the end of the investment cycle in infrastructure with the winding down of implementation expenses of this year’s new ERP (Enterprise Resource Planning) system.  Likewise, we expect to start to realize benefits from the heavy product investments of the last few years.”
About Lifeloc Technologies

Lifeloc Technologies, Inc. (OTC: LCTC) is a trusted U.S. manufacturer of evidential breath alcohol testers and related training and supplies for Workplace, Law Enforcement, Corrections and International customers.  Lifeloc stock trades over-the-counter under the symbol LCTC.  We are a fully reporting Company with our SEC filings available on our web site, www.lifeloc.com.

Forward Looking Statements

This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which involve substantial risks and uncertainties that may cause actual results to differ materially from those indicated by the forward-looking statements. All forward-looking statements expressed or implied in this press release, including statements about our strategies, expectations about new and existing products, market demand, acceptance of new and existing products, technologies and opportunities, market size and growth, and return on investments in products and market, are based on information available to us on the date of this document, and we assume no obligation to update such forward-looking statements. Investors are strongly encouraged to review the section titled “Risk Factors” in our SEC filings.

R.A.D.A.R.® is a registered trademark of Lifeloc Technologies, Inc.
SpinDx™ is a trademark of Sandia Corporation.

Sarah Foley 
Lifeloc Technologies, Inc. 
http://www.lifeloc.com 
(303) 431-9500




 
 
 
LIFELOC TECHNOLOGIES, INC.
 
Condensed Balance Sheets
 
ASSETS
 
   
September 30,
       
   
2018
   
December 31,
 
CURRENT ASSETS:
 
(Unaudited)
   
2017
 
Cash
 
$
2,657,328
   
$
2,669,455
 
Accounts receivable, net
   
724,221
     
593,326
 
Inventories, net
   
1,354,768
     
1,175,103
 
Income taxes receivable
   
53,089
     
121,401
 
Prepaid expenses and other
   
85,486
     
21,804
 
      Total current assets
   
4,874,892
     
4,581,089
 
                 
PROPERTY AND EQUIPMENT, at cost:
               
 Land
   
317,932
     
317,932
 
Building
   
1,928,795
     
1,928,795
 
Real-time Alcohol Detection And Recognition equipment and software
   
569,448
     
569,448
 
Production equipment and software
   
783,490
     
556,025
 
Training courses
   
432,375
     
432,375
 
Office equipment and software
   
270,241
     
204,282
 
Sales and marketing equipment
   
273,433
     
216,330
 
Research and development equipment and software
   
159,810
     
131,770
 
Less accumulated depreciation
   
(1,658,104
)
   
(1,349,499
 
     Total property and equipment, net
   
3,077,420
     
3,007,458
 
                 
OTHER ASSETS:
               
Patents, net
   
174,045
     
177,244
 
Deposits and other
   
5,144
     
259,037
 
Deferred taxes
   
77,782
     
66,531
 
     Total other assets
   
256,971
     
502,812
 
     Total assets
 
$
8,209,283
   
$
8,091,359
 
                 
LIABILITIES AND STOCKHOLDERS' EQUITY
 
CURRENT LIABILITIES:
               
Accounts payable
 
$
315,219
   
$
297,096
 
Term loan payable, current portion
   
42,757
     
42,101
 
Customer deposits
   
15,941
     
48,763
 
Accrued expenses
   
272,085
     
264,290
 
Deferred revenue, current portion
   
45,027
     
53,137
 
Reserve for warranty expense
   
41,000
     
40,000
 
      Total current liabilities
   
732,029
     
745,387
 
                 
TERM LOAN PAYABLE, net of current portion and
               
debt issuance costs
   
1,380,201
     
1,410,185
 
                 
DEFERRED REVENUE, net of current portion
   
10,354
     
9,683
 
                 
COMMITMENTS AND CONTINGENCIES
               
                 
STOCKHOLDERS' EQUITY:
               
Common stock, no par value; 50,000,000 shares
               
  authorized, 2,454,116 shares outstanding
   
4,593,279
     
4,580,177
 
Retained earnings
   
1,493,420
     
1,345,927
 
      Total stockholders' equity
   
6,086,699
     
5,926,104
 
      Total liabilities and stockholders' equity
 
$
8,209,283
   
$
8,091,359
 
 
 
 
 

 

LIFELOC TECHNOLOGIES, INC.
 
Condensed Statements of Income (Unaudited)
 
       
  
 
Three Months Ended September 30,
 
REVENUES:
 
2018
   
2017
 
Product sales
 
$
1,985,520
   
$
1,944,734
 
Royalties
   
46,417
     
43,785
 
Rental income
   
23,822
     
12,160
 
Total
   
2,055,759
     
2,000,679
 
                 
COST OF SALES
   
1,111,067
     
1,118,203
 
                 
GROSS PROFIT
   
944,692
     
882,476
 
                 
OPERATING EXPENSES:
               
Research and development
   
249,092
     
242,005
 
Sales and marketing
   
331,505
     
367,101
 
General and administrative
   
271,172
     
268,667
 
Total
   
851,769
     
877,773
 
                 
OPERATING INCOME
   
92,923
     
4,703
 
                 
OTHER INCOME (EXPENSE):
               
Interest income
   
7,676
     
1,036
 
Interest expense
   
(14,957
)
   
(15,261
)
Total
   
(7,281
)
   
(14,225
)
                 
NET INCOME (LOSS) BEFORE PROVISION FOR TAXES
   
85,642
     
(9,522
)
                 
(PROVISION FOR) BENEFIT FROM FEDERAL AND STATE INCOME TAXES
   
(27,478
)
   
9,712
 
                 
NET INCOME
 
$
58,164
   
$
190
 
                 
NET INCOME PER SHARE, BASIC
 
$
0.02
   
$
-
 
                 
NET INCOME PER SHARE, DILUTED
 
$
0.02
   
$
-
 
                 
WEIGHTED AVERAGE SHARES, BASIC
   
2,454,116
     
2,454,116
 
                 
WEIGHTED AVERAGE SHARES, DILUTED
   
2,504,116
     
2,511,925
 
 
 

 
LIFELOC TECHNOLOGIES, INC.
 
Condensed Statements of Income (Unaudited)
 
       
  
 
Nine Months Ended September 30,
 
REVENUES:
 
2018
   
2017
 
Product sales
 
$
6,121,553
   
$
5,706,328
 
Royalties
   
207,840
     
268,127
 
Rental income
   
57,524
     
57,075
 
Total
   
6,386,917
     
6,031,530
 
                 
COST OF SALES
   
3,446,592
     
3,171,449
 
                 
GROSS PROFIT
   
2,940,325
     
2,860,081
 
                 
OPERATING EXPENSES:
               
Research and development
   
840,647
     
690,198
 
Sales and marketing
   
997,563
     
1,074,219
 
General and administrative
   
864,629
     
858,987
 
Total
   
2,702,839
     
2,623,404
 
                 
OPERATING INCOME
   
237,486
     
236,677
 
                 
OTHER INCOME (EXPENSE):
               
Interest income
   
14,113
     
4,682
 
Interest expense
   
(47,045
)
   
(45,572
)
Total
   
(32,932
)
   
(40,890
)
                 
NET INCOME BEFORE PROVISION FOR TAXES
   
204,554
     
195,787
 
                 
PROVISION FOR FEDERAL AND STATE INCOME TAXES
   
(57,061
)
   
(49,736
)
                 
NET INCOME
 
$
147,493
   
$
146,051
 
                 
NET INCOME PER SHARE, BASIC
 
$
0.06
   
$
0.06
 
                 
NET INCOME PER SHARE, DILUTED
 
$
0.06
   
$
0.06
 
                 
WEIGHTED AVERAGE SHARES, BASIC
   
2,454,116
     
2,454,116
 
                 
WEIGHTED AVERAGE SHARES, DILUTED
   
2,504,116
     
2,520,414
 
 
 

 
LIFELOC TECHNOLOGIES, INC.
 
Condensed Statements of Cash Flows (Unaudited)
 

   
Nine Months Ended September 30,
 
CASH FLOWS FROM OPERATING ACTIVITIES:
 
2018
   
2017
 
Net income
 
$
147,493
   
$
146,051
 
Adjustments to reconcile net income to net cash
               
 provided from (used in) operating activities-
               
   Depreciation and amortization
   
320,983
     
225,310
 
   Provision for inventory obsolescence, net change
   
42,500
     
37,500
 
   Deferred taxes, net change
   
(11,251
)
   
12,836
 
   Reserve for warranty expense, net change
   
1,000
     
1,000
 
   Stock based compensation expense related to
               
     stock options
   
13,102
     
18,494
 
Changes in operating assets and liabilities-
               
   Accounts receivable
   
(130,895
)
   
(228,666
)
   Inventories
   
(222,165
)
   
(414,648
)
   Income taxes receivable
   
68,312
     
16,134
 
   Prepaid expenses and other
   
(63,682
)
   
(204
)
   Deposits and other
   
253,893
     
(145,010
)
   Accounts payable
   
18,123
     
96,348
 
   Customer deposits
   
(32,822
)
   
14,423
 
   Accrued expenses
   
7,795
     
20,889
 
   Deferred revenue
   
(7,439
)
   
(6,861
)
           Net cash provided from (used in) operating activities
   
404,947
     
(206,404
)
                 
CASH FLOWS FROM INVESTING ACTIVITIES: 
               
Purchases of property and equipment
   
(378,567
)
   
(139,736
)
Cash paid for software acquired in asset acquisition
   
-
     
(396,948
)
Cash paid for equipment acquired in asset acquisition
   
-
     
(351,250
)
Reclassification of equipment and software acquired in
               
asset acquisition as inventory
   
-
     
178,750
 
Cash paid for patents and patent applications acquired
               
in asset acquisition
   
-
     
(100,000
)
Patent filing expense
   
(6,648
)
   
(17,217
)
           Net cash (used in) investing activities
   
(385,215
)
   
(826,401
)
                 
CASH FLOWS FROM FINANCING ACTIVITIES: 
               
Principal payments made on term loan
   
(31,859
)
   
(30,335
)
           Net cash (used in) financing activities
   
(31,859
)
   
(30,335
)
                 
NET (DECREASE) IN CASH
   
(12,127
)
   
(1,063,140
)
                 
CASH, BEGINNING OF PERIOD
   
2,669,455
     
3,772,064
 
                 
CASH, END OF PERIOD
   
2,657,328
   
$
2,708,924
 
                 
SUPPLEMENTAL INFORMATION:
               
Cash paid for interest
 
$
44,270
   
$
30,040
 
                 
Cash paid for income tax
 
$
-
   
$
13,844